Aster DM Healthcare concludes separation of India and GCC businesses
The company plans to add 1700 beds by FY27 through the organic route
The company plans to add 1700 beds by FY27 through the organic route
International Business is expected to register double-digit growth in constant currency terms
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Multi-ethnic innovation helps all complexions appear clearer and more uniform
PhytoSquene now available for clinical and commercial use
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Subscribe To Our Newsletter & Stay Updated